Tortolero-Luna G - Search Results

1

Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.

Gershenson DM, Deavers M, Diaz S, Tortolero-Luna G, Miller BE, Bast RC Jr, Mills GB, Silva EG. Gershenson DM, et al. Clin Cancer Res. 1999 Dec;5(12):4053-8. Clin Cancer Res. 1999. PMID: 10632339

2

Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases.

Deavers MT, Gershenson DM, Tortolero-Luna G, Malpica A, Lu KH, Silva EG. Deavers MT, et al. Am J Surg Pathol. 2002 Sep;26(9):1129-41. doi: 10.1097/00000478-200209000-00003. Am J Surg Pathol. 2002. PMID: 12218569

3

Molecular profile of advanced-stage transitional cell carcinoma of the ovary.

Gershenson DM, Baker VV, Price JE, Hung MC, El-Naggar AK, Tortolero-Luna G, Silva EG. Gershenson DM, et al. Am J Obstet Gynecol. 1997 Jul;177(1):120-5. doi: 10.1016/s0002-9378(97)70449-6. Am J Obstet Gynecol. 1997. PMID: 9240594

4

Serous borderline tumors of the ovary with noninvasive peritoneal implants.

Gershenson DM, Silva EG, Tortolero-Luna G, Levenback C, Morris M, Tornos C. Gershenson DM, et al. Cancer. 1998 Nov 15;83(10):2157-63. doi: 10.1002/(sici)1097-0142(19981115)83:10<2157::aid-cncr14>3.0.co;2-d. Cancer. 1998. PMID: 9827720

5

Serous tumors involving extra-abdominal/extra-pelvic sites after the diagnosis of an ovarian serous neoplasm of low malignant potential.

Malpica A, Deavers MT, Gershenson D, Tortolero-Luna G, Silva EG. Malpica A, et al. Am J Surg Pathol. 2001 Aug;25(8):988-96. doi: 10.1097/00000478-200108000-00002. Am J Surg Pathol. 2001. PMID: 11474282

6

The association of benign and malignant ovarian adenofibromas with breast cancer and thyroid disorders.

Silva EG, Tornos C, Malpica A, Deavers MT, Tortolero-Luna G, Gershenson DM. Silva EG, et al. Int J Surg Pathol. 2002 Jan;10(1):33-9. doi: 10.1177/106689690201000106. Int J Surg Pathol. 2002. PMID: 11927967

7

Ovarian and extraovarian endometriosis-associated cancer.

Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK. Modesitt SC, et al. Obstet Gynecol. 2002 Oct;100(4):788-95. doi: 10.1016/s0029-7844(02)02149-x. Obstet Gynecol. 2002. PMID: 12383550

8

Mentorship and productivity among gynecologic oncology fellows.

Ramondetta LM, Bodurka DC, Tortolero-Luna G, Gordinier M, Wolf JK, Gershenson DM, Sciscione AC. Ramondetta LM, et al. J Cancer Educ. 2003 Spring;18(1):15-9. doi: 10.1207/s15430154jce1801_9. J Cancer Educ. 2003. PMID: 12825629

9

Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.

Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH. Oh JC, et al. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):748-52. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159305

10

Association between adiponectin, insulin resistance, and endometrial cancer.

Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gershenson DM, Lu KH. Soliman PT, et al. Cancer. 2006 Jun 1;106(11):2376-81. doi: 10.1002/cncr.21866. Cancer. 2006. PMID: 16639730 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page